Investor Presentaiton
Respiratory diagnostics are failing us
Spirometry: 1846
1D technology
Accurate but insensitive
20% market
CT: 1971
3D technology
Sensitive, but expensive and
high radiation dose
11% market
EME SPIROMET
Cost
Advantages:
4DMedical™
108
X-ray: 1895
2D technology
Inexpensive, but tells us very
little about airflow
67% market
USD $525 (Average estimated)
3-dimensional scan (can't miss features); Sensitive;
High-resolution detail of images
Limitations:
• Expensive: 4 times the cost of an X-ray
• High radiation dose: 70 times an X-ray
⚫ High rate of false positives (~95% in NLCST vs 3%
mortality for surgery)
Measures structure rather than function
• Very high rate of utilisation based on availability
These four technologies account for 99% of the 382 million respiratory diagnostics test
performed per annum globally
4DMedical Limited (ASX:4DX) Investor Presentation | September 2022
and
ant
10View entire presentation